Company Filing History:
Years Active: 2019-2024
Title: Innovations by Ming-Ting Huang
Introduction
Ming-Ting Huang is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical research, particularly in the treatment of neurodegenerative diseases and viral infections. With a total of 2 patents, his work showcases innovative approaches to addressing critical health challenges.
Latest Patents
Ming-Ting Huang's latest patents include groundbreaking methods for treating neurodegenerative diseases and influenza A virus infections. One of his notable inventions is a method for treating neurodegenerative diseases, such as Alzheimer's disease, using a monoclonal antibody that binds to the Siglec-3 receptor. This antibody enhances the phagocytosis of neurotoxic peptides by immune cells, providing a neuroprotective effect for individuals in need. Additionally, he has developed a method for treating influenza A virus infection through a fusion protein that combines a HBD peptide with an IgG1 Fc region. This fusion protein exhibits inhibitory effects on inflammatory responses associated with IAV infection, making it a promising candidate for therapeutic development.
Career Highlights
Ming-Ting Huang is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work has garnered attention for its potential impact on public health, particularly in the areas of neurodegenerative diseases and viral infections. His innovative approaches reflect a commitment to advancing medical science and improving patient outcomes.
Collaborations
Ming-Ting Huang collaborates with esteemed colleagues, including Shie-Liang Hsieh and Yung-Chi Chang. These partnerships enhance the research efforts and contribute to the development of effective treatments in their respective fields.
Conclusion
Ming-Ting Huang's contributions to medical research through his patents demonstrate his dedication to innovation and improving health outcomes. His work in treating neurodegenerative diseases and influenza A virus infections highlights the importance of scientific advancements in addressing global health challenges.